Cognition Therapeutics (CGTX) Amortizatization of Intangibles (2020 - 2021)
Cognition Therapeutics (CGTX) posted quarterly Amortizatization of Intangibles of $92000.0 for Q2 2021, down 64.62% quarter-over-quarter from $260000.0 in Q1 2021.
Cognition Therapeutics (CGTX) Amortizatization of Intangibles (2020 - 2021) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Amortizatization of Intangibles for 2 consecutive years, with $92000.0 the latest figure, recorded in Q2 2021.
- In Q2 2021, Amortizatization of Intangibles changed N/A year-over-year to $92000.0; the TTM figure through Dec 2021 stood at $352000.0 (changed N/A YoY), while the FY2021 annual figure was $352000.0, down 54.99% from the prior year.
- Amortizatization of Intangibles retreated to $92000.0 in Q2 2021 per CGTX's latest filing, from $260000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $260000.0 in Q1 2021 and bottomed at $92000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cognition Therapeutics | 90.18 Mn | 90.18 Mn | - | 45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 92,000.00 |
| Jun 30, 2021 | 92,000.00 |
| Mar 31, 2021 | 260,000.00 |
| Mar 31, 2021 | 260,000.00 |
| Dec 31, 2020 | 246,000.00 |
| Dec 31, 2020 | 246,000.00 |
| Sep 30, 2020 | 228,000.00 |
| Sep 30, 2020 | 228,000.00 |